Created at: Apr, 19, 2025
4:09 a.m.
Author:
curby29
Related Deck:
1701237522196
New Note
Rationale for new note
Added 5.3 Non-Steroidal Anti-Androgens (NSAAs) sketch
Extra Q
MOA: NSAAs (nonsteroidal anti-androgens)
Extra Q
MOA: NSAAs (nonsteroidal anti-androgens)
Extra A
Block testosterone by antagonizing receptor directly w/o lowering androgen levels in the body
Extra A
Block testosterone by antagonizing receptor directly w/o lowering androgen levels in the body
Extra
Extra
<img src="539890bfb3b0f19fb774bde3f866d9f7.webp">
Extra Q2
Indications (5): NSAAs
Extra Q2
Indications (5): NSAAs
Extra A2
(1) Prostate cancer
(2) Male → Female transgender therapy
(3) PCOS
(4) Priaprism
(5) Congenital adrenal hyperplasia
(2) Male → Female transgender therapy
(3) PCOS
(4) Priaprism
(5) Congenital adrenal hyperplasia
Extra A2
(1) Prostate cancer<br>(2) Male → Female transgender therapy<br>(3) PCOS<br>(4) Priaprism<br>(5) Congenital adrenal hyperplasia
Extra 2
Extra 2
<img src="6aa4b1fe7782d3fcc061ef39006813be.webp"><br><img src="39dbdb1514f5357676b33b0d49d8a7c9.webp">
Extra Q3
Common Side Effects (5): NSAAs
Extra Q3
Common Side Effects (5): NSAAs
Extra A3
(1) Gynecomastia
(2) Impotence
(3) Hot flashes
(4) Osteoporosis
(5) Nausea/Vomiting
(2) Impotence
(3) Hot flashes
(4) Osteoporosis
(5) Nausea/Vomiting
Extra A3
(1) Gynecomastia<br>(2) Impotence<br>(3) Hot flashes<br>(4) Osteoporosis<br>(5) Nausea/Vomiting
Extra 3
Name 3 First Generation NSAAs
Extra 3
Name 3 First Generation NSAAs
Extra Q4
(1) Flutamide
(2) Nilutamide
(3) Bicalutamide
(2) Nilutamide
(3) Bicalutamide
Extra Q4
(1) Flutamide<br>(2) Nilutamide<br>(3) Bicalutamide
Extra A4
Extra A4
<img src="1394ae105f9beb30258bdb578a40046f.webp"><br><img src="54f4157d1f2a3878bbd99add1a5ae007.webp"><br><img src="14aec62a38308b568af759f6cd56ee97.webp">
Extra 4
Specific Side Effect: Flutamide
Extra 4
Specific Side Effect: Flutamide
Extra Q5
Severe haptotoxicity
Extra Q5
Severe haptotoxicity
Extra A5
Extra A5
<img src="1394ae105f9beb30258bdb578a40046f.webp">
Extra 5
Specific Side Effects (3): Nilutamide
Extra 5
Specific Side Effects (3): Nilutamide
Extra Q6
(1) Interstitial pneumonitis
(2) Vision changes
(3) EtOH intolerance
(2) Vision changes
(3) EtOH intolerance
Extra Q6
(1) Interstitial pneumonitis<br>(2) Vision changes<br>(3) EtOH intolerance
Extra A6
Extra A6
<img src="54f4157d1f2a3878bbd99add1a5ae007.webp">
Extra 6
Which first generation NSAA does NOT have a risk of osteoporosis?
Extra 6
Which first generation NSAA does NOT have a risk of osteoporosis?
Extra Q7
Bicalutamide
Extra Q7
Bicalutamide
Extra A7
Extra A7
<img src="14aec62a38308b568af759f6cd56ee97.webp">
Extra 7
Name 2 second generation NSAAs
Extra 7
Name 2 second generation NSAAs
Extra Q8
(1) Apalutamide
(2) Enzalutamide
(2) Enzalutamide
Extra Q8
(1) Apalutamide<br>(2) Enzalutamide
Extra A8
Extra A8
<img src="109abceea45ddf7f44a15828add77658.webp"><br><img src="55928453343e9ff556f70eff8f5bf42d.webp">
Extra 8
Specific Side Effects (3): Apalutamide
Extra 8
Specific Side Effects (3): Apalutamide
Extra Q9
(1) Hypothyroidism
(2) Hypertension
(3) CNS effects - less than enzalutamide
(2) Hypertension
(3) CNS effects - less than enzalutamide
Extra Q9
(1) Hypothyroidism<br>(2) Hypertension<br>(3) CNS effects - less than enzalutamide
Extra A9
Extra A9
<img src="109abceea45ddf7f44a15828add77658.webp">
Extra 9
Specific Side Effects (2): Enzalutamide
Extra 9
Specific Side Effects (2): Enzalutamide
Extra Q10
(1) Back pain
(2) CNS symptoms (insomnia, anxiety, seizure-rare)
(2) CNS symptoms (insomnia, anxiety, seizure-rare)
Extra Q10
(1) Back pain<br>(2) CNS symptoms (insomnia, anxiety, seizure-rare)
Extra A10
Extra A10
<img src="55928453343e9ff556f70eff8f5bf42d.webp">
Extra 10
Empty field
Extra 10
Extra Q11
Empty field
Extra Q11
Extra A11
Empty field
Extra A11
Extra 11
Empty field
Extra 11
Extra Q12
Empty field
Extra Q12
Extra A12
Empty field
Extra A12
Extra 12
Empty field
Extra 12
Extra Q13
Empty field
Extra Q13
Extra A13
Empty field
Extra A13
Extra 13
Empty field
Extra 13
Extra Q14
Empty field
Extra Q14
Extra A14
Empty field
Extra A14
Extra 14
Empty field
Extra 14
Extra Q15
Empty field
Extra Q15
Extra A15
Empty field
Extra A15
Extra 15
Empty field
Extra 15
Extra Q16
Empty field
Extra Q16
Extra A16
Empty field
Extra A16
Extra 16
Empty field
Extra 16
Extra Q17
Empty field
Extra Q17
Extra A17
Empty field
Extra A17
Extra 17
Empty field
Extra 17
Extra Q18
Empty field
Extra Q18
Extra A18
Empty field
Extra A18
Extra 18
Empty field
Extra 18
Extra Q19
Empty field
Extra Q19
Extra A19
Empty field
Extra A19
Extra 19
Empty field
Extra 19
Extra Q20
Empty field
Extra Q20
Extra A20
Empty field
Extra A20
Extra 20
Empty field
Extra 20
Extra Q21
Empty field
Extra Q21
Extra A21
Empty field
Extra A21
Extra 21
Empty field
Extra 21
Extra Q22
Empty field
Extra Q22
Extra A22
Empty field
Extra A22
Extra 22
Empty field
Extra 22
Extra Q23
Empty field
Extra Q23
Extra A23
Empty field
Extra A23
Extra 23
Empty field
Extra 23
Extra Q24
Empty field
Extra Q24
Extra A24
Empty field
Extra A24
Extra 24
Empty field
Extra 24
Extra Q25
Empty field
Extra Q25
Extra A25
Empty field
Extra A25
Extra 25
Empty field
Extra 25
Extra Q26
Empty field
Extra Q26
Extra A26
Empty field
Extra A26
Extra 26
Empty field
Extra 26
Extra Q27
Empty field
Extra Q27
Extra A27
Empty field
Extra A27
Extra 27
Empty field
Extra 27
Extra Q28
Empty field
Extra Q28
Extra A28
Empty field
Extra A28
Extra 28
Empty field
Extra 28
Extra Q29
Empty field
Extra Q29
Extra A29
Empty field
Extra A29
Extra 29
Empty field
Extra 29
Extra Q30
Empty field
Extra Q30
Extra A30
Empty field
Extra A30
Extra 30
Empty field
Extra 30
More About This Topic
Empty field
More About This Topic
Entire Sketch
5.3 Non-Steroidal Anti-Androgens (NSAAs)
Entire Sketch
5.3 Non-Steroidal Anti-Androgens (NSAAs)<br><img src="7c3df4dbed7b6a69a5b73972d415e6f9.webp">
Sketchy Extra
Empty field
Sketchy Extra